Tci Gene (ROCO:6879) EBIT per Share : NT$0.38 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene EBIT per Share?

Tci Gene's EBIT per Share for the six months ended in Dec. 2023 was NT$0.22. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.38.

During the past 12 months, the average EBIT per Share Growth Rate of Tci Gene was -93.90% per year. During the past 3 years, the average EBIT per Share Growth Rate was -55.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Tci Gene's EBIT per Share or its related term are showing as below:

ROCO:6879' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -55 Med: -23.75 Max: 7.5
Current: -55

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Tci Gene was 7.50% per year. The lowest was -55.00% per year. And the median was -23.75% per year.

ROCO:6879's 3-Year EBIT Growth Rate is ranked worse than
90.77% of 1300 companies
in the Biotechnology industry
Industry Median: 3.4 vs ROCO:6879: -55.00

Tci Gene's EBIT for the six months ended in Dec. 2023 was NT$5.9 Mil.

Tci Gene EBIT per Share Historical Data

The historical data trend for Tci Gene's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene EBIT per Share Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

3.04

2.56

5.93

3.70

0.38

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial				3.95	3.64	0.35	0.15	0.22

Tci Gene EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Tci Gene's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	9.959	/	26.482
=	0.38

Tci Gene's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	5.923	/	26.468
=	0.22

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.38

Tci Gene (ROCO:6879) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Tci Gene EBIT per Share Related Terms

Thank you for viewing the detailed overview of Tci Gene's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines